Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$483.00
|
|
Provider: GlobalData
|
$250.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Sewon Cellontech Co. Ltd. Receives KFDA Approval
Sewon Cellontech Co. Ltd. announced that it has received Korea Food & Drug Administration (KFDA) approval, on January 17, 2012, to manufacture surgifill and ossfill.
Latest Developments for Sewon Cellontech Co Ltd
Latest Key Developments in Heavy
- Meiji Machine Co Ltd Receives Penalty Order from Securities and Exchange Surveillance Commission
- Konecranes Abp Issues Q2 2013 Operating Profit Guidance; Maintains FY 2013 Sales Guidance; Lowers FY 2013 Operating Profit Guidance
- China CNR Corp Ltd to Set up Company in Shenzhen
- Terex Corp Lowers FY 2013 EPS Guidance; Issues Q2 2013 EPS Guidance Below Analysts' Estimates
- Share this
- Link this
- Digg this
Follow Reuters